Decoy Therapeutics Inc. (DCOY) vs GlucoTrack, Inc. (GCTK)
A side-by-side comparison of Decoy Therapeutics Inc. and GlucoTrack, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DCOY
Decoy Therapeutics Inc.
$1.59HealthcareDelayed quote: Oct 6, 2026, 12:04 PM EDT
GCTK
GlucoTrack, Inc.
$1.09HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
Total return — DCOY vs GCTK
growth of $100 · dividends reinvested · last 10yDCOY -100.0% (-79.2%/yr)GCTK -100.0% (-77.2%/yr)GCTK compounded faster over this window
DCOY GCTK
DCOY vs GCTK: by the numbers
- •GCTK is the larger company ($869976 vs $845829 market cap).
Metrics side by side
Valuation
| Metric | DCOY | GCTK |
|---|---|---|
| P/B ratio | 0.20 | N/A |
Profitability
| Metric | DCOY | GCTK |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -334.41% | N/A |
| ROIC | -343.55% | N/A |
Growth (annualized)
| Metric | DCOY | GCTK |
|---|---|---|
| Total return CAGR (5Y) | -86.39% | -92.60% |
Frequently asked
- How have DCOY and GCTK total returns compared?
- Over the past 10 years, DCOY delivered -79.17% and GCTK delivered -77.25% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.